# The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients.

> **NCT06795698** · PHASE2 · COMPLETED · sponsor: **Hospital Civil de Guadalajara** · enrollment: 61 (actual)

## Conditions studied

- Fractures, Bone
- CKD Stage 4
- CKD Stage 3
- CKD Stage 5
- Enoxaparin Adverse Reaction
- Anticoagulant-induced Bleeding
- Thromboses, Venous

## Interventions

- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT06795698
- **Lead sponsor:** Hospital Civil de Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2025-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06795698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06795698, "The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06795698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*